With over seventeen years of experience in pharmaceutical sales and eight years in Oncology, I am passionate about delivering innovative solutions that improve patient outcomes and enhance quality of life. As a Precision Medicine Account Manager at Bayer, I leverage my expertise in precision medicine, comprehensive genomic profile testing, and commercial operations to establish key relationships with multiple stakeholders across priority accounts, increase the utilization of testing protocols, and influence the uptake of comprehensive genomic testing and treating the oncogenic driver sooner in the treatment paradigm. I am motivated by advancing science for a better life, and I value the opportunity to work with a diverse and collaborative team that shares the same vision and commitment.In my current role, I am responsible for driving the adoption and implementation of Bayer's precision medicine portfolio, including the TRK inhibitor Vitrakvi, in the oncology market. I work with a cross-functional team of sales, marketing, medical, and market access professionals to develop and execute account plans, communicate value propositions, overcome barriers, and provide education and support to key decision-makers and influencers. I also monitor and report on market trends, customer needs, and competitive activities, and provide feedback and insights to optimize product performance and customer satisfaction. I have successfully launched several products and programs in the oncology space, and have demonstrated strong skills in strategic planning, account management, stakeholder engagement, and problem-solving. I have years of experience in Buy-and-Bill, Field Reimbursement, Speciality Pharmacy, Rare Disease, Infusion Launches, Immuno-Oncology experience, and more.